Furthermore, elevated expression of HADH and ECHS1 has been significantly associated with cancer progression and adverse clinical outcomes across various malignancies (Du et al., 2021; Yu et al., 2023), which aligns with the results of this study. The gene discussed is HADH; the disease is cancer.